Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiji ivermectin mass drug administration for scabies
ACTRN12618000461291Phase 4Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jul 2018
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ivermectin and permethrin in scabies, sponsored by Murdoch Children's Research Institute. Primary endpoints: Hospital admissions for skin and soft tissue infection and Hospital presentations for severe bacterial complications. Started Jul 2018; status: completed.
02
Drugs
ivermectinpermethrin
03
Conditions
scabies
Beyond the preview
Go deeper on ACTRN12618000461291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000461291.